Smoking, organic solvents, and genetic susceptibility combine to increase MS risk.
Veronica Hackethal, MD
A recent study has suggested that a substance called Hm-3, which is derived from crab spider toxin, may pave the way for new treatments for a subtype of the rare neuromuscular disorder, primary periodic paralysis.
A new drug called BAN2401 has shown promise in decreasing amyloid in early AD, according to results from a phase II study.
This just in: the first study to systematically evaluate cluster headache in individuals never exposed to tobacco smoke versus those who have been exposed.
A small but noteworthy study examined whether DBS could improve motor symptoms in early PD.
Few prospective studies have been conducted to guide treatment decisions for this rare disorder. Now, a recent review describes the characteristics, diagnosis, and treatment of the group of neuromuscular disorder subtypes known as PPP.
What are the main types of ketogenic diets and what advantages do they hold for epilepsy management? Take the quiz and learn more.
A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
New research found elevated estrogen levels in nonobese men with migraine and provides evidence of lower levels of testosterone in men with migraine versus men without migraine.
Which sports-related migraine is associated with longer recovery time, as well as cognitive, neurobehavioral, and somatic symptoms? Test your skills in this quiz.